A. Wisner

779 total citations
20 papers, 671 citations indexed

About

A. Wisner is a scholar working on Genetics, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, A. Wisner has authored 20 papers receiving a total of 671 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Genetics, 12 papers in Molecular Biology and 3 papers in Cellular and Molecular Neuroscience. Recurrent topics in A. Wisner's work include Venomous Animal Envenomation and Studies (12 papers), Biochemical and Structural Characterization (7 papers) and Blood Coagulation and Thrombosis Mechanisms (3 papers). A. Wisner is often cited by papers focused on Venomous Animal Envenomation and Studies (12 papers), Biochemical and Structural Characterization (7 papers) and Blood Coagulation and Thrombosis Mechanisms (3 papers). A. Wisner collaborates with scholars based in France, Brazil and China. A. Wisner's co-authors include Cassian Bon, Yu‐Liang Xiong, Yun Zhang, Marina Parry, Amine Nejdi, Evelyne Dufour, Michaël Messaoudi, Catherine Rougeot, Marie‐Noëlle Ungeheuer and Wolfram Bode and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Biochemistry.

In The Last Decade

A. Wisner

19 papers receiving 651 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Wisner France 13 409 331 115 87 83 20 671
Li-Guo Jia United States 14 587 1.4× 498 1.5× 111 1.0× 31 0.4× 212 2.6× 15 902
Andrew B. Bicknell United Kingdom 16 318 0.8× 277 0.8× 38 0.3× 52 0.6× 153 1.8× 33 868
V. Politi Italy 14 173 0.4× 279 0.8× 44 0.4× 51 0.6× 76 0.9× 28 642
Svetlana Petruk United States 18 174 0.4× 1.3k 4.0× 51 0.4× 117 1.3× 12 0.1× 27 1.6k
Cindra Condra United States 16 149 0.4× 147 0.4× 302 2.6× 72 0.8× 9 0.1× 18 721
Jiajia Feng China 13 71 0.2× 427 1.3× 172 1.5× 62 0.7× 4 0.0× 39 902
T. Cole Germany 17 154 0.4× 551 1.7× 15 0.1× 118 1.4× 45 0.5× 24 944
Vincent Ossipow Switzerland 12 114 0.3× 619 1.9× 37 0.3× 96 1.1× 26 0.3× 14 993
Mikiko Fukuda Japan 7 400 1.0× 2.0k 6.0× 39 0.3× 37 0.4× 38 0.5× 9 2.2k
Zohra Rahmani France 16 512 1.3× 880 2.7× 28 0.2× 69 0.8× 11 0.1× 26 1.6k

Countries citing papers authored by A. Wisner

Since Specialization
Citations

This map shows the geographic impact of A. Wisner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Wisner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Wisner more than expected).

Fields of papers citing papers by A. Wisner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Wisner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Wisner. The network helps show where A. Wisner may publish in the future.

Co-authorship network of co-authors of A. Wisner

This figure shows the co-authorship network connecting the top 25 collaborators of A. Wisner. A scholar is included among the top collaborators of A. Wisner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Wisner. A. Wisner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wisner, A., Evelyne Dufour, Michaël Messaoudi, et al.. (2006). Human Opiorphin, a natural antinociceptive modulator of opioid-dependent pathways. Proceedings of the National Academy of Sciences. 103(47). 17979–17984. 146 indexed citations
2.
Guillemin, Isabelle, et al.. (2003). Sequences and structural organization of phospholipase A2 genes from Vipera aspis aspis, V. aspis zinnikeri and Vipera berus berus venom. European Journal of Biochemistry. 270(13). 2697–2706. 23 indexed citations
3.
Dekhil, Hafedh, A. Wisner, Naziha Marrakchi, et al.. (2003). Molecular Cloning and Expression of a Functional Snake Venom Serine Proteinase, with Platelet Aggregating Activity, from the Cerastes cerastes Viper,. Biochemistry. 42(36). 10609–10618. 22 indexed citations
4.
Braud, Sandrine, Bernard Le Bonniec, Cassian Bon, & A. Wisner. (2002). The Stratagem Utilized by the Plasminogen Activator from the Snake Trimeresurus stejnegeri To Escape Serpins. Biochemistry. 41(26). 8478–8484. 19 indexed citations
5.
Wisner, A., et al.. (2001). Snake Venom Proteinases as Tools in Hemostasis Studies: Structure-Function Relationship of a Plasminogen Activator Purified from <i>Trimeresurus stejnegeri </i>Venom. Pathophysiology of Haemostasis and Thrombosis. 31(3-6). 133–140. 19 indexed citations
6.
Braud, Sandrine, Marina Parry, Rachid C. Maroun, Cassian Bon, & A. Wisner. (2000). The Contribution of Residues 192 and 193 to the Specificity of Snake Venom Serine Proteinases. Journal of Biological Chemistry. 275(3). 1823–1828. 36 indexed citations
7.
Monteiro, Robson Q., et al.. (1999). Allosteric Changes of Thrombin Catalytic Site Induced by Interaction of Bothrojaracin with Anion-Binding Exosites I and II. Biochemical and Biophysical Research Communications. 262(3). 819–822. 22 indexed citations
8.
Braud, Sandrine, A. Wisner, & Cassian Bon. (1999). Venins de serpent et hémostase. 10(2). 195–206. 3 indexed citations
9.
Parry, Marina, Uwe Jacob, Robert Huber, et al.. (1998). The crystal structure of the novel snake venom plasminogen activator TSV-PA: a prototype structure for snake venom serine proteinases. Structure. 6(9). 1195–1206. 94 indexed citations
10.
Arocas, Véronique, et al.. (1997). Molecular Cloning and Expression of Bothrojaracin, A Potent Thrombin Inhibitor from Snake Venom. European Journal of Biochemistry. 248(2). 550–557. 35 indexed citations
11.
Wisner, A., et al.. (1997). Expression and site-directed mutagenesis of Trimeresurus stejnegeri snake venom plasminogen activator (TSV-PA). Toxicon. 35(4). 485–485. 1 indexed citations
12.
Zhang, Yun, A. Wisner, Rachid C. Maroun, et al.. (1997). Trimeresurus stejnegeri Snake Venom Plasminogen Activator. Journal of Biological Chemistry. 272(33). 20531–20537. 49 indexed citations
13.
Arocas, Véronique, Russolina B. Zingali, M.C. Guillin, et al.. (1996). Bothrojaracin: A potent bivalent thrombin inhibitor. Toxicon. 34(10). 1077–1077. 1 indexed citations
14.
Zhang, Yun, A. Wisner, Yu‐Liang Xiong, & Cassian Bon. (1995). A Novel Plasminogen Activator from Snake Venom. Journal of Biological Chemistry. 270(17). 10246–10255. 160 indexed citations
15.
Hamon, M., et al.. (1993). Modulation of human myometrial PGE2 receptor by GTP characterization of receptor subtype. Prostaglandins. 46(3). 251–268. 4 indexed citations
16.
17.
Wisner, A., et al.. (1990). Circadian and Estral Changes in the Hypothalamic Prostaglandin E2 Content and [3H]Prostaglandin E2 Binding in Female Rats. Journal of Neuroendocrinology. 2(2). 193–199. 1 indexed citations
18.
Dray, F., et al.. (1989). Prostaglandin E2, Leukotriene C4, and Platelet‐Activating Factor Receptor Sites in the Brain Binding Parameters and Pharmacological Studies. Annals of the New York Academy of Sciences. 559(1). 100–111. 18 indexed citations
19.
Wisner, A., et al.. (1989). Hypothalamic prostaglandin E2 receptors coupled to an adenylyl cyclase. European Journal of Pharmacology. 162(1). 89–100. 14 indexed citations
20.
Dray, F., et al.. (1985). Hypothalamic prostaglandin E2 receptors: biochemical characteristics and episodic fluctuations during rat estrus cycle.. PubMed. 15. 555–7. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Li-Guo Jia Breakdown of academic impact, for papers by Andrew B. Bicknell Breakdown of academic impact, for papers by V. Politi Breakdown of academic impact, for papers by Svetlana Petruk Breakdown of academic impact, for papers by Cindra Condra Breakdown of academic impact, for papers by Jiajia Feng Breakdown of academic impact, for papers by T. Cole Breakdown of academic impact, for papers by Vincent Ossipow Breakdown of academic impact, for papers by Mikiko Fukuda Breakdown of academic impact, for papers by Zohra Rahmani
Rankless by CCL
2026